Pharmaceutical Research and Manufacturers of America IEC

View

Source Type	Amount	Percentage
Other	$13M	100.0%
Individual	$1.9K	0.0%
Committee	$1.5K	0.0%
Total	$13M	100%

Itemized Group by Donor

Donor	Total Amount	% of Total
Sigma Tau Pharmaceuticals Other	~$X,XXX	0.1%
Wells Fargo Other	~$X,XXX	0.1%
Sunovian, Inc. Other	~$X,XXX	0.0%
Schering-Plough Corporation Other	~$X,XXX	0.0%
Medpointe Other	~$X,XXX	0.0%
Sepracor, Inc. Other	~$X,XXX	0.0%
Solvay Pharmaceuticals Other	~$X,XXX	0.0%
Valeant Other	~$X,XXX	0.0%
Serono Other	~$X,XXX	0.0%
Orexigen Other	~$X,XXX	0.0%
Novo Nordisk, Inc. Other	~$X,XXX	0.0%
Incyte Corporation Other	~$X,XXX	0.0%
Alexion Pharmaceuticals, Inc Other	~$X,XXX	0.0%
Sage Therapeutics Other	~$X,XXX	0.0%
John Valenti State Government Relations And Policy at Ipsen Biopharmaceuticals	~$X,XXX	0.0%
Assemblyman Dan Logue 2012 Officeholder Committee Committee	~$X,XXX	0.0%
Genmab Other	~$X,XXX	0.0%
Ispen Biopharmaceuticals Other	~$X,XXX	0.0%
Biogen Inc. Other	~$X,XXX	0.0%
Sunovian Pharmaceuticals, Inc. Other	~$XXX	0.0%
Franchise Tax Board Other	~$XXX	0.0%
Astrazeneca Pharmaceuticals Other	~$XXX	0.0%

Page 3 of 3